ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978

DCE Board Okays Concepts For More Than $6 Million

March 13, 1987

DCPC Board OKS P01 Grants Program In Nutrition Research

March 11, 1994

In Brief: Charles Heidelberger, Sol Spiegelman Both Die of Cancer; Robert Wittes New CTEP Director

January 28, 1983

Ohio State Schedules Workshop On CCOP

February 5, 1982

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975